Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

H. Lundbeck A Director's Dealing 2022

Jul 12, 2022

3367_rpt_2022-07-12_deab0cdd-dbd8-4cfa-ae20-f50f10bd23f7.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

H. Lundbeck A/S

Ottiliavej 9 Tel +45 36 30 13 11 E-mail [email protected] DK-2500 Valby, Copenhagen Fax +45 36 43 82 62 www.lundbeck.com CVR number: 56759913 LEI code: 5493006R4KC2OI5D3470

Corporate Release

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, July 12, 2022 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck.

In connection with the split of Lundbeck's existing shares into A-shares and B-shares completed in June 2022, the Lundbeck Foundation (via its fully owned subsidiary Lundbeckfond Invest A/S)(the Foundation) offered eligible shareholders a 1:1 exchange of their A-shares with the Lundbeck Foundation's B-shares. In accordance with Article 19 of Regulation No. 596/2014 on market abuse, Lundbeck is required to report transactions made by executives and their closely associated parties. This includes the number of shares exchanged.

Following the completion of the exchange offer, the Foundation now holds approximately 80 % of the Ashares and approximately 66 % of the B-shares. The total share capital held by the Foundation is approximately 69 % and the total voting rights held by the Foundation in Lundbeck is approximately 76 %.

1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Lundbeckfond Invest A/S
2. Reason for the notification
a) Position/status Closely associated
party due to
Lene Skole-Sørensen's
capacity as Deputy Chair of Lundbeck and CEO of
Lundbeckfond Invest A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name H. Lundbeck A/S
b) LEI code 5493006R4KC2OI5D3470
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial
instrument, type of instrument
Shares
Identification code DK0061804697 (A-shares)
DK0061804770 (B-shares)
b) Nature of the transaction Exchange of shares. The volume number indicated below is
the number of Lundbeckfond Invest A/S' B-shares exchanged
in return for other shareholders' A-shares.
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 0 22,743,609
d) Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 2022-07-09
f) Place of the transaction Outside a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Lene Skole-Sørensen
2. Reason for the notification
a) Position/status Deputy Chair of the Board of Directors of H. Lundbeck A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name H. Lundbeck A/S
b) LEI code 5493006R4KC2OI5D3470
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Shares
instrument, type of instrument
Identification code DK0061804697 (A-shares)
b) DK0061804770 (B-shares)
Nature of the transaction Exchange of shares. The volume number indicated below is
the number of B-shares received from Lundbeckfond Invest
c) Price(s) and volume(s) A/S in return for A-shares.
Price(s)
Volume(s)
d) DKK 0 DKK 12,254
Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 2022-07-09
f) Place of the transaction Outside a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Lars Erik Holmqvist
2. Reason for the notification
a) Position/status Member of the Board of Directors of H. Lundbeck A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name H. Lundbeck A/S
b) LEI code 5493006R4KC2OI5D3470
4 been conducted Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have
a) Description of the financial
instrument, type of instrument
Identification code
Shares
DK0061804697 (A-shares)
b) Nature of the transaction DK0061804770 (B-shares)
Exchange of shares. The volume number indicated below is
the number of B-shares received from Lundbeckfond Invest
A/S in return for A-shares.
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 0 DKK 15,000
d) Aggregated information
- Aggregated volume
- Price
e) Date of the transaction 2022-07-09
f) Place of the transaction Outside a trading venue

Persons under an obligation to report are defined as members of the Executive Management, members of the Board of Directors and other executives of H. Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

  • spouse or cohabitant
  • dependent children
  • legal entities in which the executive has a controlling influence.

Lundbeck contacts

Investors: Media:
Palle Holm Olesen Juliane Lenzner

[email protected] [email protected] +45 30 83 24 26 +45 36 43 40 00

Vice President, Investor Relations Vice President, Corporate Communication

About H. Lundbeck A/S

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.

An estimated 700 million people worldwide are living with brain diseases and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases – we call this Progress in Mind.

Read more at www.lundbeck.com/global/about-us/progress-in-mind.

For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck and via LinkedIn.